Pfizer Inc.
PFE
$23.97
$0.100.42%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/29/2025 | 03/30/2025 | 12/31/2024 | 09/29/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -4.75% | 112.17% | 287.45% | -98.24% |
| Total Depreciation and Amortization | -- | -6.81% | 7.32% | 12.35% | 10.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 22.33% | 205.97% | -106.88% | 98.82% |
| Change in Net Operating Assets | -- | 42.48% | -65.37% | 173.31% | 9.73% |
| Cash from Operations | -- | 114.22% | 28.26% | 94.27% | -47.43% |
| Capital Expenditure | -- | 19.89% | 12.16% | 19.63% | 30.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 57.55% | -102.11% | -182.80% | 121.34% |
| Cash from Investing | -- | 89.03% | 85.24% | -331.64% | 118.05% |
| Total Debt Issued | -- | -- | -90.46% | 9,922.73% | -85.08% |
| Total Debt Repaid | -- | 32.71% | -3,451.46% | -213.73% | -358.60% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -2.74% | -2.81% | -2.85% | -2.81% |
| Other Financing Activities | -- | 7.77% | 22.22% | 83.78% | 55.32% |
| Cash from Financing | -- | -6.00% | -193.97% | -22.68% | -109.05% |
| Foreign Exchange rate Adjustments | -- | 75.00% | -2,800.00% | 128.13% | -260.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -150.00% | 200.00% |
| Net Change in Cash | -- | 117.50% | 85.71% | -94.58% | -27.79% |